Hello, Guest!
  • Sunday, December 22, 2024

Tech Industry Vet Gil Tadmor Named DLH CTO


Gil Tadmor

Gil Tadmor, a more than 30-year information technology industry veteran, has been appointed chief technology officer of DLH Holdings.

DLH said Wednesday Tadmor will report to President and CEO Zachary Parker and oversee health IT, data analytics and big data projects with federal customers in his new position.

He joined the company in 2015 and has led its efforts to obtain a Capability Maturity Model Integration rating from the CMMI Institute and modernize a government health IT system.

He previously held different leadership roles in SCI Group and its Radiant Creative subsidiary, Ocimum Biosolutions, Broadwing Corporation and Raytheon (NYSE: RTN).

Tadmor serves as an adviser and panel member of the Johns Hopkins University Applied Physics Laboratory.

Video of the Day

Related Articles

Retired ManTech Exec Judith Bjornaas Joins DLH Board of Directors Executive Moves

Retired ManTech Exec Judith Bjornaas Joins DLH Board of Directors

Judith Bjornaas, former executive vice president and chief financial officer of ManTech, has joined the board of directors at health care and public services provider DLH Holdings (Nasdaq: DLHC). DLH’s board elected Bjornaas during its annual meeting held March 9, the company said Monday. The 38-year financial management veteran of the government services industry recently

DLH Subsidiary to Support National Cancer Institute IT Operations via $1.7B BPA; Zach Parker Quoted Contract Awards

DLH Subsidiary to Support National Cancer Institute IT Operations via $1.7B BPA; Zach Parker Quoted

A DLH Holdings (Nasdaq: DLHC) subsidiary holds a position on a $1.7 billion blanket purchase agreement for information technology services to a National Cancer Institute component. Grove Resource Solutions is among the eight vendors eligible to offer enterprise and IT support for the NCI’s Center for Biomedical Informatics and Information Technology through the five-year, multiple-award

National Cancer Institute Awards 5 Spots on $320M Epidemiology, Genetics Research Contract Contract Awards

National Cancer Institute Awards 5 Spots on $320M Epidemiology, Genetics Research Contract

Three companies and two nonprofit organizations have won spots on a potential 10-year, $320 million contract to support epidemiology and genetics research at the National Cancer Institute. Work under the indefinite-delivery/indefinite-quantity contract involves field preparation, biospecimen collection and clinical assistance to NCI’s Division of Cancer Epidemiology and Genetics, according to an award notice posted on